Two lines of evidence support a functional role of PD-L1 in the suppression of Th17 in the PBMCs: the negative correlation between RORC and PD-L1 gene expression in COPD, and the anti-PD-L1 enhancement of IL-17A production in the normal PBMCs. This evidence concerns the gene CD274 and chronic obstructive pulmonary disease.